Drug Type Small molecule drug |
Synonyms MENRIUM 10-4, MENRIUM 5-2, MENRIUM 5-4 |
Target |
Mechanism ERs agonists(Estrogen receptors agonists), GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (28 Jul 1966), |
Regulation- |
Molecular FormulaC16H14ClN3O |
InChIKeyANTSCNMPPGJYLG-UHFFFAOYSA-N |
CAS Registry58-25-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | US | 28 Jul 1966 | |
Sleep Initiation and Maintenance Disorders | US | 28 Jul 1966 |